ICPLM

BACKGROUND

With an estimated population of 258 million people, Indonesia is the fourth most populous country in the world and is categorized as lowermiddle income country with high prevalence of infectious disease cases. Epidemiological data in 2017 shown 51.19% prevalence of pneumonia in infants (Riskesdas, 2017). Furthermore, other data shown in 1990-2010, the prevalence of tetracycline resistant S. pneumoniae was raised from 21% become 46%. (The BMJ 358, 2017). Both studies the challenge of Antimicrobial Resistance (AMR) that Indonesian faces as well as the importance of new products development.

Misuse and overuse of antibiotics in humans, livestock and aquaculture drivers of resistance in this country. The use of antibiotics in agricultural and livestock products in a decade also showed an increase if compared to the use of antibiotics for the treatment of diseases. Despite current policies related to antimicrobial use, Prescribing of antibiotics and using antibiotics for self-medication by the community is still very high. Many contextual factors that tackle AMR are known, including the inadequate invention of alternative therapy and new drugs development

The improvement of knowledge regarding infectious disease therapy is needed. In order doing so, Program Study of Pharmacy, Faculty of Mathematics and Natural Science, Lambung Mangkurat University is conducting the first International conference titled “Therapeutic Strategy for Infectious Disease”. The purpose of this event is to improve knowledge and information of health professional about the current issue of infectious diseases and the latest innovations related to infectious treatment. It is also for intensive discussion between participants base on areas of interest.